Univ8 Genomics at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Univ8 Genomics brings 1 presentation to AMP 2026 in Seattle. Its session covers automated, integrated genomic profiling of blood cancers. The company makes targeted NGS assays for leukaemia, lymphoma and myeloid cancers that detect clonality, translocations, copy number changes and mutations in one test.
| Organization | AMP 2026 Attendance |
|---|---|
Univ8 Genomics Belfast, UK | |
Makes targeted NGS assays for leukaemia, lymphoma and myeloid cancers that detect clonality, translocations, copy number changes and mutations in one test. | Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. |
Instantly find 20 buyers from Univ8 Genomics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction